Shimadzu Corporation invested in Persist AI Formulation Corp (Persist AI, based in California) through the Corporate Venture Capital (CVC) fund “Shimadzu Future Innovation Fund” (Shimadzu FIF). The company is developing a platform that utilizes AI and robotics to streamline the formulation of pharmaceuticals. The formulation process, which involves processing the pharmaceutical active ingredients into useful […]

Shimadzu Corporation has invested in U.S. startup SUN METALON Inc. (Sun Metalon, Illinois) through its corporate venture capital (CVC) fund, “Shimadzu Future Innovation Fund”. Sun Metalon is developing solution to recycle scrap metal generated by the automotive, construction machinery, and steel manufacturing industries at the sites. Despite its potential value, scrap metal generated at manufacturing […]

Global life-sciences and financial leaders bring decades of health-care, biopharma, and strategic expertise to support Agilent’s next phase of growth SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been elected to its Board of Directors, […]

On March 18, Shimadzu Corporation opened the Shimadzu Kobe Innovation Lab (hereinafter, “Kobe Lab”) at the Kobe Biomedical Innovation Cluster located in Kobe city, Hyogo Prefecture. Kobe Lab will aim to expedite the development of useful microorganisms that can produce bioplastics from carbon dioxoide (CO2). By achieving a 200-fold increase in the current processing efficiency […]

THOUSAND OAKS, Calif. – Teledyne Technologies Incorporated (NYSE:TDY) (“Teledyne”​) announced today that Teledyne’s Board of Directors named George C. Bobb III as Teledyne’s President and Chief Executive Officer, effective immediately. Simultaneously, Edwin Roks has retired as Teledyne’s Chief Executive Officer, but will continue as a special advisor to Robert Mehrabian, Executive Chairman, through August 31, […]

Investment demonstrates confidence in America’s commitment to science and innovation WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector. As one of […]

Shimadzu Corporation has invested in RLWRLD Inc. (RLWRLD), through its Corporate Venture Capital (CVC) fund, “Shimadzu Future Innovation Fund” (Shimadzu FIF). RLWRLD is developing AI foundation models for humanoid and other types of robots used in the manufacturing industry. The reductions in the labor force caused by population decline and aging are emerging as social […]

Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays MUNICH–Bruker Corporation (NASDAQ: BRKR) today announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in […]

AMETEK, Inc. (NYSE: AME), is proud to announce the opening of its new Customer Solutions Center in Beijing. Designed to deliver exceptional localized customer experience, this state-of-the-art facility serves as a hub for comprehensive testing capabilities, interactive product demonstrations, and a collaborative framework for fostering innovation with Chinese customers in a wide range of applications. […]

The collaboration aims to provide advanced resources and scientific expertise to accelerate innovation and drive sustainable growth SINGAPORE — Thermo Fisher Scientific Inc, the world leader in serving science, has signed a strategic Memorandum of Understanding with NSG BIO, Singapore’s largest BSL-2-certified, co-working laboratory and office space. This collaboration aims to empower biotech startups in Singapore with access to […]